2m 2m 2m 2m 2m 2m 2m
MabCure (MBCI)
OTC
$0.0005$0.00 (0.00%)
Price as of Jun 03, 2026- N/AMarket Cap
- 400.00%1-Year Change
- SolarIndustry
MabCure (MBCI)
$0.0005$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.0005
$0.0005
$0.0005
1-Year Range
$0.000001
$0.0005
$0.0005
Latest Close$0.0005
Change
$0.00 (0.00%)
Volume289
Information as of 06/03/2026
Company Profile
MABCURE INC.
N/A
Market Cap
N/A
Net Income
Sector: Technology
Industry: Solar
21 Sparrow Circle, White Plains, NY, United States, 10605
845 591 3144MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Key Executives
- Jehu Thomas Degerold Hand
Current Ownership Distribution
- Other72.9M (99.56%)
- Insiders320,000 (0.44%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)